Early post-operative outcome of pre-pectoral implant-based immediate total breast reconstruction with Polyglactin 910 (Vicryl™) mesh - low cost solution for a low-middle income country.

BMC surgery 2024 Vol.24(1) p. 245

Vohra LM, Virji SN, Arain H, Abedin I, Zeeshan S

관련 도메인

Abstract

[BACKGROUND] The incidence of breast cancer in Pakistan has been rising with approximately one third of these patients requiring mastectomy. Among breast reconstruction treatment options, the use of Acellular Dermal Matrix (ADM) for pre-pectoral breast implant surgery has proven effective with improved cosmetic outcome. However, due to high cost it cannot be regularly implemented in a developing country like Pakistan. An alternative to ADM, Polyglactin 910 (Vicryl™, Ethicon) mesh has been introduced in pre-pectoral breast reconstructive surgery which has shown to be almost 10 times lower in cost. We set out to determine the frequency of early postoperative complications when using Polyglactin 910 mesh for pre-pectoral implant-based breast reconstruction surgery.

[METHODS] A single centre, retrospective, chart review was conducted, and a total 28 women were included in the study. Thirty-two pre-pectoral implant-based mastectomies with Polyglactin 910 mesh were performed. Early post-operative outcomes (within 12 months of procedure) including duration of antibiotic use, post-operative infection, implant displacement, flap necrosis, seroma formation, wound dehiscence, hematoma formation, capsular contracture and reconstruction failure, were recorded.

[RESULTS] Only 4 (12.5%) women experienced early post-operative morbidity. One patient developed a wound dehiscence, which eventually led to reconstruction failure and removal of the implant. Another patient had seroma formation and flap necrosis. None of the patients developed postoperative implant displacement, hematoma formation or capsular contracture in the early post-operative period.

[CONCLUSION] This study reveals that early post-operative outcomes with Polyglactin 910 mesh in breast reconstructive surgery are few, thus making it a cost effective, reliable, and safe treatment option, especially in developing countries like Pakistan.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 7
시술 flap 피판재건술 dict 2
합병증 hematoma 혈종 dict 2
합병증 seroma 장액종 dict 2
합병증 flap necrosis 괴사 dict 2
합병증 capsular contracture 피막구축 dict 2
합병증 wound dehiscence 상처열개 dict 2
재료 adm 무세포진피기질 dict 2
합병증 infection 감염 dict 1
합병증 wound scispacy 1
재료 acellular dermal matrix 무세포진피기질 dict 1
약물 [BACKGROUND] scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 breast implant C0178391
breast implant procedure
scispacy 1
질환 necrosis C0027540
Necrosis
scispacy 1
기타 patients scispacy 1
기타 women scispacy 1
기타 capsular scispacy 1
기타 patient scispacy 1

MeSH Terms

Humans; Female; Surgical Mesh; Retrospective Studies; Adult; Middle Aged; Polyglactin 910; Postoperative Complications; Mastectomy; Breast Neoplasms; Pakistan; Treatment Outcome; Breast Implantation; Mammaplasty; Breast Implants; Developing Countries

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문